Aktie 002581 SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Shandong Sinobioway Biomedicine Co., Ltd.

Aktien

002581

CNE1000012Y5

002581

Schlusskurs Shenzhen S.E.
Andere Börsenplätze
 00:00:00 26.04.2024 		% 5 Tage % 1. Jan.
12.61 CNY +0.16% Intraday Chart für Shandong Sinobioway Biomedicine Co., Ltd. +1.12% -13.63%
2023 Sinobioway Biomedicine's Einheit wird verlagert MT
2023 Shandong Sinobioway Biomedicine Co., Ltd. meldet Ergebnis für die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Sinobioway Biomedicine's Unit to Relocate
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Shandong Sinobioway Biomedicine Co., Ltd.(XSEC:002581) added to S&P Global BMI Index
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Sinobioway Biomedicine Taps Builders for Planned Industrial Park
Sinobioway Biomedicine Earmarks 1 Billion Yuan for Pharmaceutical Industrial Park
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Shandong Sinobioway Biomedicine Co., Ltd. Announces Executive Appointments
Shenzhen Yilian Technology Limited Company and Shenzhen Jialian Private Equity Investment Fund Management Co., Ltd. won the auction to acquire 8.67% stake in Shandong Sinobioway Biomedicine Co., Ltd. from Beijing Sinobioway Group Co., Ltd. for CNY 77.85 million.
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
Xiamen Hengxing Group Co., Ltd. acquired Shandong Sinobioway Biomedicine Co., Ltd. from Shenzhen Sandao Investment Management Enterprise (Limited Partnership) for CNY 200 million.
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 002581 Aktie
  4. Nachrichten Shandong Sinobioway Biomedicine Co., Ltd.
  5. Andere Sprachen